DrugBank ID stringlengths 7 7 | Accession Numbers stringlengths 7 102 ⌀ | Common name stringlengths 3 226 | CAS stringlengths 7 12 ⌀ | UNII stringlengths 10 10 ⌀ | Synonyms stringlengths 2 1.48k ⌀ | Standard InChI Key stringlengths 27 27 ⌀ |
|---|---|---|---|---|---|---|
DB19094 | null | Dimepheptanol | 545-90-4 | NNB4I01PA7 | 6-dimethylamino-4,4-diphenyl-3-heptanol | Amidol | Benzeneethanol, .beta.-(2-(dimethylamino)propyl(-.alpha.-ethyl-.beta.-phenyl- | Bimethadol | Methadol | Pangerin | Racemethadol | QIRAYNIFEOXSPW-UHFFFAOYSA-N |
DB19095 | null | Elivaldogene tavalentivec | 1905397-73-0 | VI2NBA6B8C | A vsv-g*-pseudotyped self-inactivating hiv-1-derived lentiviral vector (plbp100 hald) encoding human adrenoleukodystrophy (ald) protein (abcd1 gene) under the control of a modified myeloproliferative sarcoma virus promoter | Dna (lentiviral vector clone lenti-d human x-linked adrenoleukodystrophy abcd1 gene cdna-specifying) | Elivaldogene tavalentivec | Lenti-d | Lenti-d drug product | null |
DB19096 | null | Verekitug | 2768386-15-6 | T1NAO7YDA7 | Verekitug | null |
DB19097 | null | THR-184 | 930274-80-9 | 616BV6U9G8 | L-CYSTEINYL-L-TYROSYL-L-TYROSYL-L-.ALPHA.-ASPARTYL-L-ASPARAGINYL-L-SERYL-L-SERYL-L-SERYL-L-VALYL-L-LEUCYL-L-CYSTEINYL-L-LYSYL-L-ARGINYL-L-TYROSYL-L-ARGINYL-L-SERINE | null |
DB19098 | null | Pegsitacianine | 2396651-85-5 | 49X2Q41T99 | Pegsitacianine | null |
DB19099 | null | Mazdutide | 2259884-03-0 | MB76Z4IBZ5 | Mazdutide | null |
DB19100 | null | Gotistobart | 2226344-78-9 | 4R46M31XXP | Gotistobart | null |
DB19101 | null | Bosakitug | 2762183-23-1 | 5T953J9HZN | Bosakitug | null |
DB19102 | null | Adrenomedullin | 154835-90-2 | QA0A21Y20D | null | null |
DB19103 | null | Simoladagene autotemcel | null | MOD3RG31RS | Simoladagene autotemcel | null |
DB19104 | null | Upinitatug rilsodotin | 2254119-00-9 | E8US1SQ3B5 | Anti-napi2b/auristatin f-hpa adc xmt-1536 | Antibody-drug conjugate adc xmt-1536 | null |
DB19105 | null | Tivanisiran | 1848224-71-4 | 2H47U2SBVO | Rna, (a-a-g-c-g-c-a-u-c-u-u-c-u-a-c-u-u-c-a), complex with rna (u-g-a-a-g-u-a-g-a-a-g-a-u-g-c-g-c-u-u) (1:1) | null |
DB19106 | null | Drozitumab | 912628-39-8 | SQ67484MA7 | Anti-dr5 rhumab-dr5 | Immunoglobulin g1, anti-(human citokine receptor dr5 (death receptor 5)) (human monoclonal heavy chain), disulfide with human l3-chain, dimer | Rhumab dr5 | Rhumab-dr5 | Usp mab 003, monoclonal igg1 | null |
DB19107 | null | Rivogenlecleucel | null | E6349B696W | Rivogenlecleucel | null |
DB19108 | null | SPH-3127 | 1399849-02-5 | C2M78A9V6Z | CARBAMIC ACID, N-(3-(3-((1R)-1-(CYCLOPROPYL((2R)-2-MORPHOLINYLCARBONYL)AMINO)ETHYL)-6-METHYL-1H-PYRAZOLO(3,4-B)PYRIDIN-1-YL)PROPYL)-, METHYL ESTER | GRTDDIZIUSADLD-CRAIPNDOSA-N |
DB19109 | null | Isuzinaxib | 1270084-92-8 | YP664UDC7T | 1-(pyridin-2-yl)-3-phenyl-4-propyl-1h-pyrazol-5-ol | 1h-pyrazol-5-ol, 3-phenyl-4-propyl-1-(2-pyridinyl)- | 3-phenyl-4-propyl-1-(2-pyridinyl)-1h-pyrazol-5-ol | 3-phenyl-4-propyl-1-(pyridin-2-yl)-1h-pyrazol-5-ol | Apx-115 free base | Ewha-18278 free base | LQKQLKMTJOMCMJ-UHFFFAOYSA-N |
DB19110 | null | JNJ-55308942 | 2166558-11-6 | B7YN3CQ7S7 | ((6S)-1-(5-FLUORO-2-PYRIMIDINYL)-1,4,6,7-TETRAHYDRO-6-METHYL-5H-1,2,3-TRIAZOLO(4,5-C)PYRIDIN-5-YL)(3-FLUORO-2-(TRIFLUOROMETHYL)-4-PYRIDINYL)METHANONE | (S)-(3-Fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1H-[1,2,3]triazolo[4,5-c]pyridin-5(4H)-yl)methanone | 5-fluoro-2-[(6S)-5-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]-6-methyl-1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridin-1-yl]pyrimidine | METHANONE, ((6S)-1-(5-FLUORO-2-PYRIMIDINYL)-1,4,6,7-TETRAHYDRO-6-METHYL-5H-1,2,3-TRIAZOLO(4,5-C)PYRIDIN-5-YL)(3-FLUORO-2-(TRIFLUOROMETHYL)-4-PYRIDINYL)- | LMDWZBQISRTEBH-QMMMGPOBSA-N |
DB19111 | null | KER-047 | 2248154-85-8 | 8DLP7XK3VH | QUINOLINE, 7-FLUORO-6-METHOXY-4-(6-(4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)- | UYQADNMBNQEQQG-UHFFFAOYSA-N |
DB19112 | null | Kisspeptin | 388138-21-4 | 2VG74ZW2K5 | Kiss-1 metastasis suppressor | Metastin | null |
DB19113 | null | Fosclevudine alafenamide | 1951476-79-1 | 77AP23J0GH | L-alanine, n-((s)-hydroxyphenoxyphosphinyl)-, 1-methylethyl ester, 5'-ester with 1-(2-deoxy-2-fluoro-.beta.-l-arabinofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione | FTMNZJASLMPPNW-MHFVGYLCSA-N |
DB19114 | null | EA-230 | 503844-09-5 | EJB8KD4JLL | (2S)-2-((2-(((2S)-5-AMINO-2-(((2S)-2-AMINOPROPANOYL)AMINO)-5-OXO-PENTANOYL)AMINO)ACETYL)AMINO)-3-METHYL-BUTANOIC ACID | L-valine, l-alanyl-l-glutaminylglycyl- | DXRXYJYFADHAPA-AUTRQRHGSA-N |
DB19115 | null | Lactide, L- | 4511-42-6 | IJ13TO4NO1 | (-)-l-dilactide | 1,4-dioxane-2,5-dione, 3,6-dimethyl-, (3s-cis)- | 1,4-dioxane-2,5-dione, 3,6-dimethyl-, (3s,5s)- | 1,4-dioxane-2,5-dione, 3,6-dimethyl-, (3s,6s)- | L-(-)-lactide | L-dilactide | L-lactide | L,l-dilactide | Ll-lactide | P-dioxane-2,5-dione, 3,6-dimethyl-, l- | Purasorb l | JJTUDXZGHPGLLC-IMJSIDKUSA-N |
DB19116 | null | Trimethylene carbonate | 2453-03-4 | 4316AQ174Q | 1,3-carbonyldioxypropane | 1,3-dioxan-2-one | 1,3-propanediol, cyclic carbonate | Cyclic trimethylene carbonate | M-dioxan-2-one | YFHICDDUDORKJB-UHFFFAOYSA-N |
DB19117 | null | Lapuleucel-t | 845680-07-1 | J5Z87L8ROA | null | null |
DB19118 | null | Tuparstobart | 2649466-03-3 | Z0A08C63DF | Anti-LAG-3 Monoclonal Antibody INCAGN02385 | gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV1-46*02 (80.4%)-(IGHD) -IGHJ4*01 (100%), CDR-IMGT[8.8.14] (26-33.51-58.97-110)) (1-121)-Homo sapiens IGHG1*03, G1m3, nG1m1, G1v29 CH2 A84.4 (CH1 R120 (218) (122-219), hinge 1-15 (220-234), CH2 N8 | Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human lymphocyte activation gene-3 protein) (human-Mus musculus monoclonal INCAGN02385 γ1-chain), disulfide with human-Mus musculus monoclonal INCAGN02385 κ-chain, dimer | immunoglobulin G1-kappa,anti-[Homo sapiens LAG3 (lymphocyte activating 3, lymphocyte-activation 3, CD223)], humanized monoclonal antibody | null |
DB19119 | null | Timbetasin | 77591-33-4 | 2D5MRE3SSY | 3,11,25,31,38-pentakis(de-n6-acetyl)-1,22,30,33-tetrakis(de-o3-phosphono)thymosin .beta.4(human) | Ac-ser-asp-lys-pro-asp-met-ala-glu-ile-glu-lys-phe-asp-lys-ser-lys-leu-lys-lys-thr-glu-thr-gln-glu-lys-asn-pro-leu-pro-ser-lys-glu-thr-ile-glu-gln-glu-lys-gln-ala-gly-glu-ser | L-SERINE, N-ACETYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LYSYL-L-PROLYL-L-.ALPHA.-ASPARTYL-L-METHIONYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-L-LYSYL-L-PHENYLALANYL-L-.ALPHA.-ASPARTYL-L-LYSYL-L-SERYL-L-LYSYL-L-LEUCYL-L-LYSYL-L-LYSYL-L-THREONYL | N-ACETYL-L-SERYL-L-ASPARTYL-L-LYSYL-L-PROLYL-L-ASPARTYL-L-METHIONYL-L-ALANYL-L-GLUTAMYL-L-ISOLEUCYL-L-GLUTAMYL-L-LYSYL-L-PHENYLALANYL-L-ASPARTYL-L-LYSYL-L-SERYL-L-LYSYL-L-LEUCYL-L-LYSYL-L-LYSYL-L-THEONYL-L-GLUTAMYL-L-THEONYL-L-GLUTAMINYL-L-GLUTAMYL-L-LYS | Thymosin .beta.(4), 3,11,25,31,38-pentakis(de-n6-acetyl)-1,22,30,33-tetrakis(de-o3-phosphono)- | null |
DB19120 | null | Sotevtamab | 2411526-47-9 | YQ3YJK67AF | Immunoglobulin g2, anti-(human clusterin .beta.-chain) (human-mus musculus monoclonal ab-16b5 .gamma.2-chain), disulfide with human-mus musculus monoclonal ab-16b5 .kappa.-chain, dimer | null |
DB19121 | null | Redasemtide | 1606186-88-2 | OVE619G496 | Met-gly-lys-gly-asp-pro-lys-lys-pro-arg-gly-lys-met-ser-ser-tyr-ala-phe-phe-val-gln-thr-cys-arg-glu-glu-his-lys-lys-lys-his-pro-asp-ala-ser-val-asn-phe-ser-glu-phe-ser-lys-lys | null |
DB19122 | null | Nisin Z | 137061-46-2 | KOS9259QVA | Nisin a, 27-l-asparagine- | Nisin nisin z | Nisin, 27-l-asparagine- | null |
DB19123 | null | Enzalutamide d3 | 1443331-82-5 | 3OKI556HC2 | 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-n-(methyl-d3)benzamide | Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-n-(methyl-d3)- | DEUTENZALUTAMIDE | Enzalutamide d3 | WXCXUHSOUPDCQV-HPRDVNIFSA-N |
DB19124 | null | Genipin | 6902-77-8 | A3V2NE52YG | (+)-genipin | Cyclopenta(c)pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester, (1r-(1.alpha.,4a.alpha.,7a.alpha.))- | Cyclopenta(c)pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester, (1r,4as,7as)- | Cyclopenta(c)pyran-4-carboxylic acid, 1,4a.alpha.,5,7a.alpha.-tetrahydro-1-hydroxy-7-(hydroxymethyl)-, methyl ester | AZKVWQKMDGGDSV-BCMRRPTOSA-N |
DB19125 | null | Giredestrant | 1953133-47-5 | 28P3DU6DB3 | (1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)-3-azetidinyl)amino)phenyl)-.beta.,.beta.-difluoro-1,3,4,9-tetrahydro-3-methyl-2h-pyrido(3,4-b)indole-2-propanol | 2h-pyrido(3,4-b)indole-2-propanol, 1-(2,6-difluoro-4-((1-(3-fluoropropyl)-3-azetidinyl)amino)phenyl)-.beta.,.beta.-difluoro-1,3,4,9-tetrahydro-3-methyl-, (1r,3r)- | 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido(3,4-b)indol-2-yl)-2,2-difluoropropan-1-ol | GQCXHIKRWBIQMD-AKJBCIBTSA-N |
DB19126 | null | R906289 | 2602614-45-7 | FZC82L3L2B | null | ZSSREAXVWYYKJC-ZCQHSFHSSA-N |
DB19127 | null | Radotermin | 575458-75-2 | 1Y9ZQO99Y1 | Growth differentiation factor 5 (human), homodimer | Recombinant human growth and differentiation factor-5 | null |
DB19128 | null | Ralmitaront | 2133417-13-5 | QA8MW1Q80P | 1h-pyrazole-3-carboxamide, 5-ethyl-4-methyl-n-(4-(2s)-2-morpholinylphenyl)- | 5-ethyl-4-methyl-n-(4-((2s)-morpholin-2-yl)phenyl)-1h-pyrazole-3-carboxamide | XHHXGKRFUPEPFM-OAHLLOKOSA-N |
DB19129 | null | Inupadenant | 2246607-08-7 | HQ700V0X06 | (+)-5-amino-3-(2-(4-(2,4-difluoro-5-(2-((s)-methanesulfinyl)ethoxy)phenyl)piperazin-1- yl)ethyl)-8-(furan-2-yl)thiazolo(5,4-e)(1,2,4)triazolo(1,5-c)pyrimidin-2(3h)-one | Thiazolo(5,4-e)(1,2,4)triazolo(1,5-c)pyrimidin-2(3h)-one, 5-amino-3-(2-(4-(2,4-difluoro-5-(2-((s)-methylsulfinyl)ethoxy)phenyl)-1-piperazinyl)ethyl)-8-(2-furanyl)- | Thiazolo(5,4-e)(1,2,4)triazolo(1,5-c)pyrimidin-2(3h)-one, 5-amino-3-(2-(4-(2,4-difluoro-5-(2-(methylsulfinyl)ethoxy)phenyl)-1-piperazinyl)ethyl)-8-(2-furanyl)-, (+)- | QYCCLUSYHJXDEX-RWYGWLOXSA-N |
DB19130 | null | Relmapirazin | 1313706-17-0 | Q3UQB8PQ6H | D-serine, n,n'-((3,6-diamino-2,5-pyrazinediyl)dicarbonyl)bis- | Lumitrace | N,n'-((3,6-diamino-2,5-pyrazinediyl)dicarbonyl)bis(d-serine) | XHNJXRDGTITISI-QWWZWVQMSA-N |
DB19131 | null | Remlarsen | 1848266-71-6 | X2MD0LH19A | Rna, (am-am-cm-a-cm-um-g-um-um-um-a-cm-a-a-a-um-g-g-um-cm-cm-um-a), 3'-(3-((6-((3.beta.)-cholest-5-en-3-yloxy)hexyl)oxy)-2-hydroxypropyl hydrogen phosphate), complex with rna ((2'-deoxy-2'-fluoro)u-a-g-(2'-deoxy-2'-fluoro)c-a-(2'-deoxy-2'-fluoro)c-(2'-de | null |
DB19132 | null | Renadirsen | 1782108-31-9 | 4RW6WRD7SW | Renapersen | DYDGGTWPZKPVKH-UHFFFAOYSA-N |
DB19133 | null | Rezvilutamide | 1572045-62-5 | 70FJN2AW22 | 4-(3-(4-((s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile | Benzonitrile, 4-(3-(4-((2s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)- | KRBMOYIWQCZVHA-INIZCTEOSA-N |
DB19134 | null | Ropanicant | 2414674-70-5 | S3VP91C4JO | (1r,3s,5r)-3-(((6-chloropyridin-3-yl)oxy)methyl)-2-azabicyclo(3.1.0)hexane | 2-azabicyclo(3.1.0)hexane, 3-(((6-chloro-3-pyridinyl)oxy)methyl)-, (1r,3s,5r)- | Ropanicant, (+)- | PYSCVJMLJRHJGJ-OYNCUSHFSA-N |
DB19135 | null | Sanfetrinem cilexetil | 141646-08-4 | 7322RJ9FZB | 1-hydroxyethyl (1s,5s,8as,8br)-1,2,5,6,7,8,8a,8b-octahydro-1-((r)-1-hydroxyethyl)-5-methoxy-2-oxoazeto(2,1-a)isoindole-4-carboxylate, cyclohexyl carbonate (ester) | QFEICXCLIGZEJB-IRVPUMQPSA-N |
DB19136 | null | Scarlet red | 85-83-6 | I35E9QU96C | 1-((2-methyl-4-((2-methylphenyl)azo)phenyl)azo)-2-naphthalenol | 2-naphthalenol, 1-((2-methyl-4-((2-methylphenyl)azo)phenyl)azo)- | 2-naphthol, 1-(4-o-tolylazo-o-tolylazo)- | 2',3-dimethyl-4-(2-hydroxynaphthylazo) azobenzene | C.i. solvent red 24 | Fast oil red b | Grasal brilliant red b | Oil red b | Scarlet oil | Scarlet red | Solvent red 24 (scarlet red) | Sudan iv | RCTGMCJBQGBLKT-PAMTUDGESA-N |
DB19137 | null | Batoprotafib | 1801765-04-7 | FPJWORQEGI | (3s,4s)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)sulfanyl)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro(4.5)decan-4-amine | PTPN11 inhibitor TNO155 | SHP2 inhibitor TNO155 | UCJZOKGUEJUNIO-IINYFYTJSA-N |
DB19138 | null | Suplatast | 94055-75-1 | 4T0HO29O56 | Sulfonium, (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethyl- | Suplatast cation | Suplatast ion | DYZJXZOQQRXDLE-UHFFFAOYSA-O |
DB19139 | null | Suvecaltamide | 953778-58-0 | MIA4WMP8QN | 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)benzeneacetamide | Benzeneacetamide, 4-(1-methylethyl)-n-((1r)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)- | Suvecaltamide | IQIKXZMPPBEWAD-CQSZACIVSA-N |
DB19140 | null | Evexomostat | 2416263-67-5 | Z7116W3IFA | METAP2 inhibitor SDX-7320 | Poly((n-(2-hydroxypropyl)methacrylamide)-co-(methacryloyl-gly-phe-leu-gly amide with o-((trans-4-aminocyclohexyl)carbamoyl)fumagillol)) (~0.91:0.09 x) | null |
DB19141 | null | Tetraarsenic tetrasulfide | 12279-90-2 | ZIK02R2PSD | Arsenic disulfide | Arsenic disulphide | Arsenic monosulfide | Arsenic monosulphide | Arsenic sulfide | Arsenic sulfide red | Arsenic sulphide red | Arsenicum sulphuratum rubrum | Arsino, thioxo- | Realgar | Red arsenic glass | Ruby arsenic | Tetra-arsenic tetra-sulfide | Tetra-arsenic tetra-sulphide | Tetraarsenic tetrasulphide | Xionghuang | XPDICGYEJXYUDW-UHFFFAOYSA-N |
DB19142 | null | Tanfanercept | 2119738-70-2 | Z39Q6AB0ZR | 41-211-tumor necrosis factor receptor 1 | L-methionyl-(l28>v,s52>m,h55>f,r57>p,h58>g,k121>n) tumor necrosis factor (tnf) binding protein variant 1 (tbp-1) with c-terminal extension by further 10 residues of the pro-protein, human, unglycosylated | null |
DB19143 | null | PF-07038124 | 2415085-44-6 | M6ZU548FWD | null | KXVKOYCGACSUPP-INIZCTEOSA-N |
DB19144 | null | Technetium Tc-99m maraciclatide | null | H0X34CV8RR | Maraciclatide Tc-99m | Tc-99m Maraciclatide | Technetium Tc-99m maraciclatide | null |
DB19145 | null | Baltaleucel-T | null | F9670LP52I | Baltaleucel | null |
DB19146 | null | Limonene, (+/-)- | 138-86-3 | 9MC3I34447 | (+/-)-1-methyl-4-(1-methylethenyl)cyclohexene | (+/-)-limonene | 1-methyl-4-(1-methylethenyl)cyclohexene | 4-isopropenyl-1-methyl-1-cyclohexene | Cajeputene | Cinene | Cyclohexene, 1-methyl-4-(1-methylethenyl)- | Dipenten | Dipentene | Eulimen | Kautschin | Limonene | Limonene, ()- | Limonene, dl- | Nesol | Orange x | Terpin monohydrate impurity c | XMGQYMWWDOXHJM-UHFFFAOYSA-N |
DB19147 | null | Mecapegfilgrastim | 1570067-55-8 | I4QL0KKG3K | Poly(oxy-1,2-ethanediyl), .alpha.-(((2-((3-(3-((3-aminopropyl)thio)-2,5-dioxo-1-pyrrolidinyl)-1-oxopropyl)amino)ethyl)amino)carbonyl)-.omega.-methoxy-, reaction products with granulocyte colony-stimulating factor (methionyl)(human) | null |
DB19148 | null | NUC-7738 | 2348493-39-8 | Y7BFN2M72F | Fosdesdenosine Sipalabenamide | L-Alanine, N-(3′-deoxy-P-phenyl-5′-adenylyl)-, phenylmethyl ester (ACI) | UDLWWGQHMQIYCV-LKKHFEEPSA-N |
DB19149 | null | NYX-2925 | 2012536-16-0 | X062KF5ZV3 | (αS,4R)-α-[(1R)-1-Hydroxyethyl]-5-(2-methyl-1-oxopropyl)-1-oxo-2,5-diazaspiro[3.4]octane-2-acetamide | X062KF5ZV3 | NFXPEHLDVKVVKA-ISTVAULSSA-N |
DB19150 | null | Arketamine | 33643-49-1 | Y2RI13H7VW | (+)-ketamine | (r)-(+)-ketamine | (r)-ketamine | Arketamine | Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (2r)- | Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+)- | D-ketamine | Ketamine, r- | YQEZLKZALYSWHR-CYBMUJFWSA-N |
DB19151 | null | Arasertaconazole | 583057-48-1 | PR82C5R514 | 1-((2r)-2-((7-chloro-1-benzothiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole | 1h-imidazole, 1-((2r)-2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)- | Arasertaconazole | Sertaconazole, (r)- | JLGKQTAYUIMGRK-IBGZPJMESA-N |
DB19152 | null | Pyrrolidone | 616-45-5 | KKL5D39EOL | .alpha.-pyrrolidone | 2-pyrrolidinone | 2-pyrrolidone | 2-tetrahydropyrrolone | Butyrolactam | Gamma-aminobutyrolactam | Povidone impurity b | Pyrrolid-2-one | HNJBEVLQSNELDL-UHFFFAOYSA-N |
DB19153 | null | MK-8189 | 1424371-93-6 | 7M430JI73B | 4-PYRIMIDINAMINE, 2-METHYL-6-(((1S,2S)-2-(5-METHYL-2-PYRIDINYL)CYCLOPROPYL)METHOXY)-N-((5-METHYL-1,3,4-THIADIAZOL-2-YL)METHYL)- | WQKPZDLZRFTMTI-CABCVRRESA-N |
DB19154 | null | Mocemestrocel | null | 8HM51ZKE1F | null | null |
DB19155 | null | Nalotimagene carmaleucel | null | 2SS05WO6EV | HSV-TK | human culture expanded activated allogeneic T cells for adjunctive immunotherapy. Cells are derived from the haematopoietic stem cell (HSC) donor and are genetically modified ex vivo with a non-replicative SFCMM-3 gamma- retroviral vector derived from Mo | null |
DB19156 | null | Ovemotide | 181477-91-8 | 704120HM0H | (264-l-valine)melanocyte protein pmel 17 (human melanoma-associated me20 antigen)-(256-264)-peptide | Elagigiltv | Gp100:280-288(288V) peptide | L-valine, l-tyrosyl-l-leucyl-l-.alpha.-glutamyl-l-prolylglycyl-l-prolyl-l-valyl-l-threonyl- | MART-1:26-35(27L) peptide | Tyr-leu-glu-pro-gly-pro-val-thr-val | null |
DB19157 | null | Zirconium (89Zr) crefmirlimab berdoxam | 2377668-38-5 | J6AJI0OZ1O | Iab22m2c (antibody fragment against the human cd8-antigen on cd8-positive t-cells, conjugated to the chelator desferrioxamine (df) and labeled with the radioisotope zirconium Zr-89) | zirconium (⁸⁹Zr) crefmirlimab berdoxam | ZIRCONIUM ZR 89 CREFMIRLIMAB BERDOXAM | Zirconium zr 89-df-iab22m2c | Zirconium Zr-89 crefmirlimab berdoxam | Zirconium Zr-89-desferrioxamine-iab22m2c | null |
DB19158 | null | p-Boronophenylalanine | 76410-58-7 | JSM63LV5MD | 4-borono-l-phenylalanine | Borofalan | L-p-boronophenylalanine | L-phenylalanine, 4-borono- | NFIVJOSXJDORSP-QMMMGPOBSA-N |
DB19159 | null | Pyrrolizidine | 643-20-9 | U81KWZ2JKN | 1-azabicyclo(3.3.0)octane | 1h-pyrrolizine, hexahydro- | Hexahydropyrrolizine | ADRDEXBBJTUCND-UHFFFAOYSA-N |
DB19160 | null | Quemliclustat | 2105904-82-1 | J6K8WSV73A | 1h-pyrazolo(3,4-b)pyridin-4-amine, 6-chloro-n-((1s)-1-(2-fluorophenyl)ethyl)-1-(5-o-(hydroxy(phosphonomethyl)phosphinyl)-.beta.-d-ribofuranosyl)- | 2-chloro-n6 -((1s)-1-(2-fluorophenyl)ethyl)-8-aza-1,7- dicarbaadenosine 5'-(trihydrogen 2-carbadiphosphate) | MFYLCAMJNGIULC-KCVUFLITSA-N |
DB19161 | null | Pudexacianinium | 2243793-21-5 | 8L74RU1KOY | .beta.-cyclodextrin, 2a-o-(3-aminopropyl)-, diamide with 3-(2-carboxyethyl)-2-(2-(3-(2-(3-(2-carboxyethyl)-1,3-dihydro-1,1-dimethyl-2h-benz(e)indol-2-ylidiene)ethylidene)-2-methoxy-1-cyclohexen-1-yl)ethylene)-1,1-dimethyl-1h-benz(e)indolium ion | 3-(3-((3-(CYCLOMALTOHEPTAOS-21-O-YL)PROPYL)AMINO)-3-OXOPROPYL)-2-((1E)-2-((3E)-3-((2E)-2-(3-(3-((3-(CYCLOMALTOHEPTAOS-21-O-YL)PROPYL)AMINO)-3-OXOPROPYL)-1,1-DIMETHYL-1,3-DIHYDRO-2H-BENZO(E)INDOL-2-YLIDENE)ETHYLIDENE)-2-METHOXYCYCLOHEX-1-EN-1-YL)ETHEN-1-Y | Pudexacianinium ion | YTSRTYDSGUUGAS-ZKNIEEHQSA-O |
DB19162 | null | (R)-Propafenone | 107381-31-7 | X44T90MGR0 | (+)-(r)-propafenone | (+)-propafenone | (R)-propafenone | 1-propanone, 1-(2-((2r)-2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl- | JWHAUXFOSRPERK-GOSISDBHSA-N |
DB19163 | null | PF-06835919 | 2102501-84-6 | EC2P9H3A8S | (1α,5α,6α)-3-[2-[(2S)-2-Methyl-1-azetidinyl]-6-(trifluoromethyl)-4-pyrimidinyl]-3-azabicyclo[3.1.0]hexane-6-acetic acid | 2-((1S,5R)-3-(2-((2S)-2-METHYLAZETIDIN-1-YL)-6-(TRIFLUOROMETHYL)PYRIMIDIN-4-YL)-3-AZABICYCLO(3.1.0)HEXAN-6-YL)ACETIC ACID | MDUYWDNWFXSMJJ-XWLWVQCSSA-N |
DB19164 | null | Phenazepam | 51753-57-2 | 3DSB43090Z | 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-bromo-5-(2-chlorophenyl)- | 2h-1,4-benzodiazepin-2-one, 7-bromo-5-(2-chlorophenyl)-1,3-dihydro- | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one | Fenazepam | Phenzitat | CGMJQQJSWIRRRL-UHFFFAOYSA-N |
DB19165 | null | Pirepemat | 1227638-29-0 | JS88RK5NOI | (3s)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine | Pyrrolidine, 3-(2,3-difluorophenyl)-3-methoxy-, (+)- | Pyrrolidine, 3-(2,3-difluorophenyl)-3-methoxy-, (3s)- | LJNFYMMXCXGFCP-LLVKDONJSA-N |
DB19166 | null | Pixatimod | 1144617-49-1 | 66QR34C83N | Pg-545 free acid | LNUFLCYMSVYYNW-ZPJMAFJPSA-N |
DB19167 | null | Poloxamine 1304 | 11111-34-5 | 19BHK0H429 | Tetronic 1304 | null |
DB19168 | null | Dexamethasone palmitate | 14899-36-6 | 601XWN7060 | 9-fluoro-11,17-dihydroxy-16-methyl-21-((1- oxohexadecyl)oxy)pregna-1,4-diene-3,20-dione (11.beta.,16.alpha.)- | Dexamethasone 21-palmitate | WDPYZTKOEFDTCU-WDJQFAPHSA-N |
DB19169 | null | Pamapimod | 449811-01-2 | 8S2C9V11K4 | 6-(2,4-Difluorophenoxy)-2-{[3-hydroxy-1-(2-hydroxyethyl)propyl]amino}-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one | JYYLVUFNAHSSFE-UHFFFAOYSA-N |
DB19170 | null | Pemrametostat | 1616392-22-3 | VXT8SZ6875 | 4-pyrimidinecarboxamide, 6-((1-acetyl-4-piperidinyl)amino)-n-((2s)-3-(3,4-dihydro-2(1h)-isoquinolinyl)-2-hydroxypropyl)- | 6-((1-acetyl-4-piperidinyl)amino)-n-((2s)-3-(3,4-dihydro-2(1h)-isoquinolinyl)-2-hydroxypropyl)-4-pyrimidinecarboxamide | Protein arginine methyltransferase 5 inhibitor gsk3326595 | JLCCNYVTIWRPIZ-NRFANRHFSA-N |
DB19171 | null | Ectoine | 96702-03-3 | 7GXZ3858RY | (4s)-3,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid | Ectoin | WQXNXVUDBPYKBA-YFKPBYRVSA-N |
DB19172 | null | Emoxypine | 2364-75-2 | V247P5H4E1 | 2-ethyl-3-hydroxy-6-methylpyridine | 2-ethyl-6-methyl-3-hydroxypyridine | 2-ethyl-6-methyl-3-pyridinol | 3-pyridinol, 2-ethyl-6-methyl- | 6-methyl-2-ethyl-3-hydroxypyridine | Emoxipin | Emoxipine | Emoxypin | Epigid | Epygid | Ethylmethylhydroxypyridine | Methylethylpiridinol | JPGDYIGSCHWQCC-UHFFFAOYSA-N |
DB19173 | null | Gamma cyclodextrin | 17465-86-0 | KZJ0BYZ5VA | .gamma.-cyclodextrin | Alfadex impurity b | Cavamax w8 | Cyclodextrin, gamma- | Cyclomaltooctaose | Cyclooctaamylose | Cyclooctakis-(1->4)-(.alpha.-d-glucopyranosyl) | Gamma-cyclodextrin | Ringdex c | GDSRMADSINPKSL-HSEONFRVSA-N |
DB19174 | null | EMI-137 | null | IT54DZ1478 | EMI-137 (fluorescent peptide targeted against c-met) | GE-137 (agscycsgpprfecwcyetegt-gggk-cy5**) | null |
DB19175 | null | Hyaluronic acid (non-animal stabilized) | 9004-61-9 | B7SG5YV2SI | Durolane | Hyaluronan (non animal) | Hyaluronic acid (NASHA) | Perlane | Restylane | null |
DB19176 | null | Boclatixafortide gallium Ga-68 | 2356354-82-8 | Y92N1ZLI87 | [68Ga]Ga-PentixaFor | 68GA)PENTIXAFOR | GA-68 PENTIXAFOR | GALLIUM (68GA) BOCLATIXAFORTIDE | GALLIUM BOCLATIXAFORTIDE GA-68 | PENTIXAFOR GALLIUM GA-68 | CUSSKFGZGIXQLJ-LXKHRIOFSA-K |
DB19177 | null | PXS-4728A free base | 1478364-40-7 | MFI2XG2PVK | Benzamide, 4-(((2e)-2-(aminomethyl)-3-fluoro-2-propen-1-yl)oxy)-n-(1,1-dimethylethyl)- | OWNSXNXYELKDSO-DHZHZOJOSA-N |
DB19178 | null | OSU-6162 | 146798-66-5 | 0D21EQAQQA | null | GZVBVBMMNFIXGE-CQSZACIVSA-N |
DB19179 | null | Luxeptinib | 1616428-23-9 | TQ6PBX1JU0 | 32,72,74,76-tetrafluoro-14-methyl-21,23-dihydro-11h-4,6-diaza-2(4,7)-isoindola- 1(2)-imidazola-3(1,4),7(1)-dibenzenaheptaphane-2,35-dione | Luxeptinib | Urea, n-(4-(2,3-dihydro-7-(5-methyl-1h-imidazol-2-yl)-1-oxo-1h-isoindol-4-yl)-3-fluorophenyl)-n'-(2,4,6-trifluorophenyl)- | MWHHJYUHCZWSLS-UHFFFAOYSA-N |
DB19180 | null | NV-5138 | 2095886-80-7 | 06CA9QMG6Z | ((S)-2-AMINO-5,5-DIFLUORO-4,4-DIMETHYLPENTANOIC ACID | Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2s)- | HRFIMCJTDKEPPV-BYPYZUCNSA-N |
DB19181 | null | ER-176 C-11 | 1623028-18-1 | WC5YF463BE | 2-quinazolinecarboxamide, 4-(2-chlorophenyl)-n-(methyl-11c)-n-((1r)-1-methylpropyl)- | ASFLYNMYGAYKON-XFBLKYPGSA-N |
DB19182 | null | Dapiglutide | 2296814-85-0 | J43GMI6IYW | Human glucagon like peptide-2 (glp-2) analogue; n6.16-(n-(17-carboxyheptadecanoyl)-l-.gamma.-glutamyl)- (a2>aib (2-methylalanine), d3>e, s7>t, d8>s, m10>l, n11>a, n16>k, l17>q, n24>a, t29>h)human glucagonlike peptide 2 (glp-2) | L-ASPARTIC ACID, L-HISTIDYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-SERYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-GLUTAMYL-L-LEUCYL-L-ALANYL-L-THREONYL-L-ISOLEUCYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-N6-(N-(17-CARBOXY-1-OXOHEPTADECYL)-L-.GAMMA.-GLUTAMYL)-L | null |
DB19183 | null | Onvitrelin ucalontide | 1620643-19-7 | UF1EL37E41 | Ep-100 (conjugate of luteinizing hormone-releasing hormone with a cationic .alpha.-helical peptide for therapy of lhrh-expressing tumors) | Ep-100 (peptide) | Membrane-disrupting peptide ep-100 | null |
DB19184 | null | CV-8102 | null | ULM5THL8W5 | Rna-based adjuvant cv8102 | RNADJUVANT | Ssrna-based immunomodulator cv8102 | null |
DB19185 | null | Bifikafusp alfa | 1957239-90-5 | 2K7BN4G2DQ | Immunoglobulin, anti-(human fibronectin ed-b domain) (synthetic human clone l19 scfv fragment) fusion protein with human interleukin 2 | null |
DB19186 | null | Gonyautoxin II | 60508-89-6 | YU77Z3NY6Z | 1h,10h-pyrrolo(1,2-c)purine-9,10,10-triol, 2,6-diamino-4-(((aminocarbonyl)oxy)methyl)-3a,4,8,9-tetrahydro-, 9-(hydrogen sulfate), (3as-(3a.alpha.,4.alpha.,9.beta.,10ar*))- 11.alpha.-hydroxysaxitoxin 11-sulfate | Gonyautoxin 2 | Gonyautoxin iim | ARSXTTJGWGCRRR-XXKOCQOQSA-N |
DB19187 | null | Gonyautoxin III | 60537-65-7 | 1FFI43DL2K | (+)-gonyautoxin 3 | 11.beta.-hydroxysaxitoxin 11-sulfate | 1h,10h-pyrrolo(1,2-c)purine-9,10,10-triol, 2,6-diamino-4-(((aminocarbonyl)oxy)methyl)-3a,4,8,9-tetrahydro-, 9-(hydrogen sulfate), (3as-(3a.alpha.,4.alpha.,9.alpha.,10ar*))- 11-sulfate | 1h,10h-pyrrolo(1,2-c)purine-9,10,10-triol, 2,6-diamino-4-(((aminocarbonyl)oxy)methyl)-3a,4,8,9-tetrahydro-, 9-(hydrogen sulfate), (3as,4r,9s,10as)- | Gonyautoxin 3 | Gonyautoxin iiim | Gtx iii | ARSXTTJGWGCRRR-LJRZAWCWSA-N |
DB19188 | null | Cenplacel-L | null | OOH12XV6XR | ALLOGENEIC-UNRELATED PLACENTA-DERIVED STROMAL CELLS, EXPANDED EX VIVO | CENPLACEL-L COMPONENT OF PDA-001 | CENPLACEL-L COMPONENT OF PDA-002 | HUMAN PLACENTA-DERIVED ADHERENT (PDA) CELLS THAT ARE CULTURE-EXPANDED, UNDIFFERENTIATED MESENCHYMAL-LIKE CELLS DERIVED FROM FULL-TERM PLACENTAL TISSUE. CELLULAR IDENTITY: MESENCHYMAL-LIKE STROMAL CELL: CD34-, CD10+, CD105+, AND CD200+. | null |
DB19189 | null | DPA-714 F-18 | 958233-09-5 | 0VMV8Z3972 | N,n-diethyl-(2-(4-(2-(18f)fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidine-3-yl)acetamide | Pyrazolo(1,5-a)pyrimidine-3-acetamide, n,n-diethyl-2-(4-(2-(fluoro-18f)ethoxy)phenyl)-5,7-dimethyl- | FLZZFWBNYJNHMY-VNRZBHCFSA-N |
DB19190 | null | Londamocitinib | 2241039-81-4 | JAC34RRR7S | (R)-N-(3-(5-Fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide | 1-piperazineacetamide, n-(3-(5-fluoro-2-((2-fluoro-3-(methylsulfonyl)phenyl)amino)-4-pyrimidinyl)-1h-indol-7-yl)-.alpha.-(methoxymethyl)-4-methyl-, (.alpha.r)- | JNUZADQZHYFJGW-JOCHJYFZSA-N |
DB19191 | null | Valiltramiprosate | 1034190-08-3 | GHG2B47067 | 1-propanesulfonic acid, 3-(((2s)-2-amino-3-methyl-1-oxobutyl)amino)- | 3-((2s)-2-amino-3-methylbutamido)propane-1-sulfonic acid | NRZRFNYKMSAZBI-ZETCQYMHSA-N |
DB19192 | null | Methylone | 186028-79-5 | L4I4B1R01F | 1-propanone, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)- | 3,4-methylenedioxy-n-methylcathinone | MDMC | Methylenedioxymethcathinone | Methylone | VKEQBMCRQDSRET-UHFFFAOYSA-N |
DB19193 | null | CFG-920 | 1260006-20-9 | UP0K5026VB | 1-(2-CHLORO-4-PYRIDINYL)-3-(4-METHYL-3-PYRIDINYL)-2-IMIDAZOLIDINONE | 2-imidazolidinone, 1-(2-chloro-4-pyridinyl)-3-(4-methyl-3-pyridinyl)- | ZVIFCOOHWGNPHJ-UHFFFAOYSA-N |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.